Precision's Comprehensive Tumor
Profiles offer a portfolio of products developed to help guide
physicians and patients with difficult clinical decisions throughout
the Cancer Care Continuum.
Precision’s ongoing array of multiple products and technologies provide
unique clinical value through a Comprehensive Tumor Profile, which
includes:
ChemoFx®,
BioSpeciFx®
and
GeneFx Colon®.
This approach to precision medicine combines genomic expression and
molecular information specific and clinically relevant to a patient’s
cancer, answering a broad range of clinical questions that physicians
encounter every day while managing their patient’s care.


Precision
Therapeutics is now HelomicsTM
Like Precision, Helomics is dedicated to improving the
outcomes of cancer patients by providing personalized healthcare
solutions that aim to increase quality of life and cancer survival
rates.